Background/aim: We evaluated the relationship between serum alarmin levels and disease-specific indices in patients with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV). Patients and methods: Sera and data from 79 patients were utilized. For AAV-specific indices, Birmingham vasculitis activity score (BVAS), five-factor score (FFS), and vasculitis damage index (VDI) were collected and serum levels of four alarmins (hepatoma-derived growth factor, high mobility group box protein 1, S100A9, and S100A12) were measured using enzyme-linked immunosorbent assay. Associations between alarmin levels, AAV-specific indices, and inflammatory laboratory markers were assessed. Results: S100A9 levels were significantly correla...
Previous studies observed the high prevalence of venous thromboembolism in patients with antineutrop...
Background: To differentiate between a relapse with increased inflammatory activity and lasting effe...
Objective. To evaluate circulating cytokine profiles in patients with antineutrophil cytoplasmic ant...
Background: This study investigated whether serum progranulin could act as a predictive marker for h...
Objectives: Cysteine-rich protein 61 (CYR61) stimulates protein kinase B (Akt)-mediated nuclear fact...
Purpose: We investigated whether serum clusterin levels could reflect the current antineutrophil cyt...
Background: Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitides (AAV) are systemic in...
Objective To identify circulating proteins that distinguish between active anti-neutrophil cytoplasm...
Background: In this study, the serum B-cell activating factor belonging to tumor necrosis factor fam...
Background: In anti-neutrophil cytoplasmic antibody-mediated vasculitis (AAV), uncontrolled systemic...
Objective Improved biomarkers of current disease activity and prediction of relapse are needed in an...
Objective To identify biomarkers that distinguish between active antineutrophil cytoplasmic antibody...
To access publisher's full text version of this article, please click on the hyperlink in Additional...
Objectives: Chronic primary systemic vasculitidies (CPV) are a collection of rare diseases involving...
OBJECTIVES: We investigated whether serum soluble programmed cell death protein 1 (sPD-1) could pred...
Previous studies observed the high prevalence of venous thromboembolism in patients with antineutrop...
Background: To differentiate between a relapse with increased inflammatory activity and lasting effe...
Objective. To evaluate circulating cytokine profiles in patients with antineutrophil cytoplasmic ant...
Background: This study investigated whether serum progranulin could act as a predictive marker for h...
Objectives: Cysteine-rich protein 61 (CYR61) stimulates protein kinase B (Akt)-mediated nuclear fact...
Purpose: We investigated whether serum clusterin levels could reflect the current antineutrophil cyt...
Background: Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitides (AAV) are systemic in...
Objective To identify circulating proteins that distinguish between active anti-neutrophil cytoplasm...
Background: In this study, the serum B-cell activating factor belonging to tumor necrosis factor fam...
Background: In anti-neutrophil cytoplasmic antibody-mediated vasculitis (AAV), uncontrolled systemic...
Objective Improved biomarkers of current disease activity and prediction of relapse are needed in an...
Objective To identify biomarkers that distinguish between active antineutrophil cytoplasmic antibody...
To access publisher's full text version of this article, please click on the hyperlink in Additional...
Objectives: Chronic primary systemic vasculitidies (CPV) are a collection of rare diseases involving...
OBJECTIVES: We investigated whether serum soluble programmed cell death protein 1 (sPD-1) could pred...
Previous studies observed the high prevalence of venous thromboembolism in patients with antineutrop...
Background: To differentiate between a relapse with increased inflammatory activity and lasting effe...
Objective. To evaluate circulating cytokine profiles in patients with antineutrophil cytoplasmic ant...